Tamer Coskun Selected Research

Tamer Coskun Research Topics

Disease

26	Body Weight (Weight, Body) 11/2023 - 12/2008
21	Obesity 08/2023 - 12/2008
16	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2013
10	Insulin Resistance 11/2023 - 07/2013
10	Weight Loss (Weight Reduction) 08/2023 - 01/2012
5	Vomiting 12/2023 - 12/2018
5	Nausea 12/2023 - 12/2018
4	Dyslipidemias (Dyslipidemia) 07/2023 - 01/2012
4	Atherosclerosis 01/2023 - 10/2017
2	Heart Failure 01/2023 - 10/2017
2	Neoplasms (Cancer) 01/2020 - 10/2017
2	Hyperglycemia 01/2017 - 01/2017
1	Constipation 12/2023
1	Weight Gain 11/2023
1	Hyperphagia (Overeating) 11/2023
1	Non-alcoholic Fatty Liver Disease 07/2023
1	AIDS-Related Complex (ARC) 01/2023
1	Cardiomegaly (Heart Hypertrophy) 01/2023
1	Body Weight Changes 01/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2022
1	Anorexia 01/2020
1	Cachexia 10/2017
1	Metabolic Diseases (Metabolic Disease) 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 01/2017
1	Glucose Intolerance 01/2017
1	Cysts 04/2016
1	Hypertension (High Blood Pressure) 09/2015
1	Osteoporosis 01/2014
1	Hypercalcemia (Milk Alkali Syndrome) 01/2014

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 01/2012
8	Glucagon-Like Peptide-1 ReceptorIBA 02/2024 - 12/2018
8	LipidsIBA 11/2023 - 10/2015
7	tirzepatideIBA 11/2023 - 12/2018
7	Peptides (Polypeptides)IBA 01/2023 - 04/2011
6	Insulin (Novolin)FDA Link 11/2023 - 07/2013
6	fibroblast growth factor 21IBA 01/2020 - 12/2008
5	gastric inhibitory polypeptide receptorIBA 02/2024 - 01/2022
4	retatrutideIBA 12/2023 - 01/2022
4	Glucagon (Glukagon)FDA Link 11/2022 - 01/2022
3	dulaglutideIBA 12/2023 - 10/2020
3	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023 - 01/2015
3	Glucagon Receptors (Glucagon Receptor)IBA 12/2023 - 01/2022
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2023 - 12/2018
3	CholesterolIBA 07/2023 - 01/2020
3	Triglycerides (Triacylglycerol)IBA 07/2023 - 07/2013
3	Blood Glucose (Blood Sugar)IBA 01/2023 - 07/2013
2	semaglutideIBA 01/2023 - 01/2022
2	orforglipronIBA 01/2023 - 01/2023
2	LeptinIBA 01/2023 - 01/2017
2	Peptide YYIBA 01/2022 - 01/2015
2	EndocannabinoidsIBA 01/2021 - 01/2018
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 10/2017 - 01/2012
1	RNA (Ribonucleic Acid)IBA 11/2023
1	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2023
1	Rosiglitazone (Avandia)FDA Link 11/2023
1	Hormones (Hormone)IBA 08/2023
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 01/2023
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	RelaxinIBA 01/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2023
1	IsotopesIBA 10/2022
1	AcidsIBA 10/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Cholecystokinin (Pancreozymin)IBA 01/2022
1	SolutionsIBA 01/2022
1	Appetite Depressants (Anorectics)IBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2021
1	CannabinoidsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Colesevelam Hydrochloride (Welchol)FDA Link 01/2020
1	CytokinesIBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 12/2019
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 07/2019
1	Oxytocin (Pitocin)FDA LinkGeneric 07/2019
1	IncretinsIBA 12/2018
1	N-acylethanolaminesIBA 01/2018
1	anandamide (arachidonylethanolamide)IBA 01/2018
1	3- (4- ((4- fluoro- 4'- methyl- (1,1'- biphenyl)- 2- yl)methoxy)phenyl)propanoic acidIBA 01/2018
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2018
1	Growth Differentiation Factor 15IBA 10/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2017
1	4-O-carboxymethylascochlorinIBA 01/2017
1	AdiponectinIBA 11/2016
1	CarbohydratesIBA 10/2015
1	Indicators and Reagents (Reagents)IBA 09/2015
1	ReninIBA 09/2015
1	compound 18IBA 01/2015
1	Myelin P0 Protein (Myelin Protein Zero)IBA 07/2013

Therapy/Procedure

9	Glycemic Control 11/2023 - 07/2013
4	Therapeutics 01/2023 - 01/2014
2	Subcutaneous Injections 07/2023 - 01/2023
1	Injections 01/2023
1	Arthroscopes 04/2016